Evidence map›Paper›PMID 42576628›Full record

ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2026

[Development and integration of ASP assessment tools for bacteraemia and infections caused by multidrug-resistant microorganisms in paediatrics].

Marta Echávarri-de-Miguel, Pablo Ciudad-Gutiérrez, Beatriz Leal-Pino, Belén Riva-de-la-Hoz, Aida Sánchez-García, Marta Taida García-Ascaso, Margarita Cuervas-Mons Vendrell

Abstract readEnglish Abstract
In one paragraph

Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta Echávarri-de-MiguelServicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España.ORCID 0009-0006-0340-6489
Pablo Ciudad-GutiérrezServicio de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, España.ORCID 0000-0002-6757-3247
Beatriz Leal-PinoServicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España. bleal@salud.madrid.org.ORCID 0009-0003-9768-5359
Belén Riva-de-la-HozServicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España.ORCID 0009-0000-4949-9322
Aida Sánchez-GarcíaSección de Microbiología, Hospital Infantil Universitario Niño Jesús, Madrid, España.ORCID 0009-0008-5996-9453
Marta Taida García-AscasoUnidad de Enfermedades Infecciosas, Hospital Infantil Universitario Niño Jesús, Madrid, España.ORCID 0000-0003-2763-2182
Margarita Cuervas-Mons VendrellServicio de Farmacia, Hospital Infantil Universitario Niño Jesús, Madrid, España.ORCID 0000-0003-4137-6621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntimicrobial resistance is a major global public health challenge with particular implications in pediatrics. Antimicrobial stewardship programs (ASPs) require structured tools to assess prescribing quality, especially in complex clinical scenarios such as bloodstream infections and multidrug-resistant organism infections. The aim of this study was to design and implement a structured support program for managing these infections in a pediatric hospital, including an evaluation tool, a standard operating procedure, and its integration into the electronic health record. MATERIAL AND

methodsThe program was developed in 2025 within the ASP team of a tertiary pediatric hospital. Two evaluation tools were designed based on the AFinf methodology of the Spanish Society of Hospital Pharmacy and quality indicators reported in the literature. A standard operating procedure was developed in accordance with the PROA certification standards, and the tools were integrated into the hospital's electronic prescribing system.

resultsTwo structured evaluation tools were obtained (23 items for bloodstream infections and 21 for multidrug-resistant organisms), organized across four dimensions: patient identification, diagnostic adequacy, antimicrobial treatment adequacy, and ASP intervention. A multidisciplinary care pathway was formalized, and electronic integration was completed, enabling systematic data analysis.

conclusionsThe program represents a feasible strategy aligned with current ASP certification standards, with the added value of being specifically designed for the pediatric population, a setting where dedicated and validated tools remain a pressing need.

Indexed as

Antimicrobial StewardshipBacteremiaDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsChildElectronic Health RecordsHospitals, PediatricHumansPediatricsAnti-Bacterial AgentsAntimicrobial stewardshipBacteraemiaHealthcare quality indicatorsMicrobial drug resistancePaediatrics

Identifiers

PMID42576628
PMCPMC13633495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.